For research use only. Not for therapeutic Use.
Depatuxizumab Mafodotin (Depatux-M, ABT-414) is an antibody-drug conjugate consisting of an EGFR IGg1 monoclonal antibody conjugated to the tubulin inhibitor monomethyl auristatin F via a stable maleimidocaproyl link. Depatuxizumab Mafodotin is used in the treatment of recurrent EGFR-amplified Glioblastoma (GBM).
| Catalog Number | I047244 |
| Purity | ≥95% |
| Reference | [1] Padovan M, et al. Cancers (Basel). 2021 Jun 3;13(11):2773. |
